Rein Therapeutics (RNTX) Q2 2025 Earnings

15MayConfirmed
Q4 2024
Q2 2025
-0.27
-0.25
-0.23
-0.21

Details

Expected EPS
-0.21
Actual EPS
-0.25
Surprise EPS
-0.04
Surprise Percent
+19.05%

Description

Rein Therapeutics (RNTX) has reported earnings of -0.25 per share for Q2 2025.

0 Comments

Share your thoughts